BSP Pharmaceuticals is a Contract Development and Manufacturing Organization fully dedicated to antineoplastic drugs, designed to handle the complexity of biopharmaceutical products and offering customized services to support its client from development to commercial manufacturing of injectables and oral formulations. BSP Pharmaceuticals is focused on innovative therapies such as Proteosome Inhibitors, Antibody Drug Conjugates (ADCs) , Liposomal formulations, handling the major platforms of ADC compounds currently in clinical and commercial phase.
Sartorius-Stedim Biotech is a key supplier of Bioprocessing technologies and Biomanufacturing related services.
Benefit from the most comprehensive bioprocess and single-use technology portfolio coupled with our process engineering expertise, ensuring a robust process development and manufacturing approach… Read more
OcellO is an innovative biotech company offering services for drug discovery and early drug development. OcellO excels in clinically relevant in vitro 3D tumoroid assays, using Patient-derived xenograft (PDX) models and primary tumor cells (‘in vitro clinical trials’). We are experienced in working with…
Novasep provides unique services for the development and cGMP manufacture of antibody-drug conjugates including the payload, the linker and the monoclonal antibody. With a recent €10M investment in a fully integrated ADC facility, Novasep has reinforced its current ADC offering with full bio-conjugation services to meet increasing market demand.
For over 25 years, Lonza has been helping emerging biotech and pharmaceutical companies improve and advance their products. Whether you are in the early stages of clinical development or providing commercial product to patients around the globe, Lonza supplies complete development services, industry-leading manufacturing, and broad technology platforms that enable products to reach their full potential… Read More
Quality Assistance is one of the few Analytical CRO in the world able to provide the combination of expertise in NCEs and biologics required to fully characterize ADCs and perform batch release, stability testing, PK/TK, Immunogenicity and biomarkers studies during (pre)clinical phases. The company has 30 years’ experience and 150 highly qualified employees.
SCIEX enables drug discovery and development for biologics and small molecule drugs. From identification through peptide mapping and sequence variance analysis ― our advanced LC/MS, LC/MS/MS and CE solutions reduce complexity across the entire process. SCIEX strives to exceed expectations and empower customers to find accurate answers.
Genovis provides unique enzymes suitable for development and characterization of ADCs, mAbs, proteins, Fc-fusion proteins and biosimilars.
The SmartEnzymes™ portfolio consists of:
- FabRICATOR® (IdeS), FabRICATOR®Z (IdeZ), FabULOUS® (SpeB) and GingisKHAN™ (Kgp). These enzymes are for preparation of subunits for further analysis using LC and MS.
- IgGZERO® (EndoS) and GlycINATOR… Read more